These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis. Nagappa M; Taly AB; Sinha S; Gayathri N; Bindu PS; Mahadevan A; Yasha T J Clin Neuromuscul Dis; 2013 Jun; 14(4):161-8. PubMed ID: 23703010 [TBL] [Abstract][Full Text] [Related]
25. Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine. Grigg A; Chapman R; Szer J Bone Marrow Transplant; 1998 Mar; 21(6):619-21. PubMed ID: 9543067 [TBL] [Abstract][Full Text] [Related]
26. A pilot trial of rituximab in the treatment of patients with dermatomyositis. Chung L; Genovese MC; Fiorentino DF Arch Dermatol; 2007 Jun; 143(6):763-7. PubMed ID: 17576943 [TBL] [Abstract][Full Text] [Related]
27. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. Marie I; Hachulla E; Hatron PY; Hellot MF; Levesque H; Devulder B; Courtois H J Rheumatol; 2001 Oct; 28(10):2230-7. PubMed ID: 11669162 [TBL] [Abstract][Full Text] [Related]
29. Clinical spectrum of inflammatory myositis in South India--a ten year study. Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis). Pongratz D J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756 [TBL] [Abstract][Full Text] [Related]
31. The role of MRI in the assessment of polymyositis and dermatomyositis. Tomasová Studynková J; Charvát F; Jarosová K; Vencovsky J Rheumatology (Oxford); 2007 Jul; 46(7):1174-9. PubMed ID: 17500079 [TBL] [Abstract][Full Text] [Related]
32. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Allanore Y; Vignaux O; Arnaud L; Puéchal X; Pavy S; Duboc D; Legmann P; Kahan A Ann Rheum Dis; 2006 Feb; 65(2):249-52. PubMed ID: 16410529 [TBL] [Abstract][Full Text] [Related]
33. Inflammatory myopathies: evaluation and management. Greenberg SA Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. Danieli MG; Malcangi G; Palmieri C; Logullo F; Salvi A; Piani M; Danieli G Ann Rheum Dis; 2002 Jan; 61(1):37-41. PubMed ID: 11779756 [TBL] [Abstract][Full Text] [Related]
35. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Riley P; Maillard SM; Wedderburn LR; Woo P; Murray KJ; Pilkington CA Rheumatology (Oxford); 2004 Apr; 43(4):491-6. PubMed ID: 14722349 [TBL] [Abstract][Full Text] [Related]
36. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis. McKendry RJ Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101 [TBL] [Abstract][Full Text] [Related]
37. [Patient with eosinophilic polymyositis]. de Kruijf EJ; Rothbarth J; van Duinen SG; de Meijer PH; Meinders AE Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2019-23. PubMed ID: 11072522 [TBL] [Abstract][Full Text] [Related]
38. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. András C; Ponyi A; Constantin T; Csiki Z; Szekanecz E; Szodoray P; Dankó K J Rheumatol; 2008 Mar; 35(3):438-44. PubMed ID: 18203322 [TBL] [Abstract][Full Text] [Related]
39. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Limaye VS; Lester S; Blumbergs P; Roberts-Thomson PJ Int J Rheum Dis; 2010 May; 13(2):132-7. PubMed ID: 20536597 [TBL] [Abstract][Full Text] [Related]